Iodide

Iodide

SCHEMBL7571966

CC(C)Cc1ccc(C(C)C(=O)CCCCCCCCCOC(=O)c2cccnc2)cc1.I

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.56
L3MBTL1 Q9Y468 1/20 0.52
MAPT P10636 3/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 1/20 0.48
TDP1 Q9NUW8 1/20 0.42
FAAH O00519 1/20 0.42
PTGS1 P23219 4/20 0.41
PTGS2 P35354 3/20 0.41
NFKB1 P19838 3/20 0.41
CYP2C9 P11712 2/20 0.41
AKR1C3 P42330 2/20 0.41
CXCR1 P25024 2/20 0.41
CXCR2 P25025 2/20 0.41
ALB P02768 1/20 0.41
ESR1 P03372 1/20 0.41
ALOX5 P09917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31259763 0.84 RAB9A (0.55) LMNAL3MBTL1KMT2ARAB9ATDP1
SCHEMBL25329826 0.84 RAB9A (0.55) LMNAL3MBTL1KMT2ARAB9ATDP1
SCHEMBL29242263 0.77 LMNA (0.73) LMNAL3MBTL1MAPTKMT2AMEN1
SCHEMBL29067692 0.77 LMNA (0.73) LMNAL3MBTL1MAPTKMT2AMEN1
SCHEMBL10458609 0.77 LMNA (0.73) LMNAL3MBTL1MAPTKMT2AMEN1
SCHEMBL10458600 0.77 LMNA (0.73) LMNAL3MBTL1MAPTKMT2AMEN1
SCHEMBL21243071 0.75 LMNA (0.82) LMNAL3MBTL1MAPTKMT2AMEN1
SCHEMBL4478304 0.75 RAB9A (0.59) LMNARAB9AFAAHPTGS1PTGS2
SCHEMBL4482367 0.75 RAB9A (0.59) LMNARAB9AFAAHPTGS1PTGS2
SCHEMBL14937203 0.74 L3MBTL1 (0.72) LMNAL3MBTL1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020160988-A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160988-A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof CHAT, ACHE, CHRNB2 LMNA 4005/4885L3MBTL1 1442/4885MAPT 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.